Skip to main navigation Skip to search Skip to main content

Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B

  • Heejoon Jang
  • , Jun Sik Yoon
  • , Soo Young Park
  • , Han Ah Lee
  • , Myoung jin Jang
  • , Seung Up Kim
  • , Dong Hyun Sinn
  • , Yeon Seok Seo
  • , Hwi Young Kim
  • , Sung Eun Kim
  • , Dae Won Jun
  • , Eileen L. Yoon
  • , Joo Hyun Sohn
  • , Sang Bong Ahn
  • , Jae Jun Shim
  • , Soung Won Jeong
  • , Yong Kyun Cho
  • , Hyoung Su Kim
  • , Joon Yeul Nam
  • , Yun Bin Lee
    • Yoon Jun Kim, Jung Hwan Yoon, Fabien Zoulim, Pietro Lampertico, George N. Dalekos, Ramazan Idilman, Vana Sypsa, Thomas Berg, Maria Buti, Jose Luis Calleja, John Goulis, Spilios Manolakopoulos, Harry LA Janssen, George V. Papatheodoridis, Jeong Hoon Lee

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology